Discovere-ESO Podcasts
e-ESO Podcasts
Claim Ownership

e-ESO Podcasts

Author: ESO - European School of Oncology

Subscribed: 15Played: 517
Share
© ESO - European School of Oncology

Description

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net
123 Episodes
Reverse
Meta-Analysis: How to do it?

Meta-Analysis: How to do it?

2021-06-1014:24

Expert: Luca Bertolaccini,  European Institute of Oncology, Milan, Italy 1-What is a systematic review_meta analysis 2-What is the clinical question that needs to be answered 3-How to perform a correct search strategy 4-How to perform the study selection 5-How to perform the statistical analysis
From clinical and academic culture in radiation oncology - how to cross the chasm?

From clinical and academic culture in radiation oncology - how to cross the chasm?

2024-05-3015:45

Expert: Vincent Grégoire, Centre Léon Bérard, Lyon, FR
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

2024-05-1605:38

Expert: Radwa Hamed Sabra, Lecturer of Clinical Oncology, Armed Forces College of Medicine Egypt, Cairo, Egypt
Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

2024-04-3011:16

Experts: Paula Fidalgo, Centro Hospitalar Universitário de Santo António, Porto, PT João Coelho, Centro Hospitalar Universitário de Santo António, Porto, PT
Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

2024-04-1802:59

Expert: Panagiotis J. Vlachostergios, Weill Cornell Medicine, New York, NY, USA
The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

2024-04-0410:34

Expert: Franco Cavalli, Foundation for the Institute for Oncology Research (IOR), Bellinzona, Switzerland
Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

2024-03-2005:09

Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil
An inter-specialty cancer training programme curriculum for Europe

An inter-specialty cancer training programme curriculum for Europe

2024-03-0706:55

Kim Benstead, Co-Chair INTERACT-EUROPE Project, Cheltenham, UK
Communicating the oncological diagnosis: a psycho-oncological perspective

Communicating the oncological diagnosis: a psycho-oncological perspective

2024-02-2214:46

Expert: Adrian Pogacian, INCKA Psycho-Oncology Center, Târgu Mures, Romania
ESMO 2023 Highlights on lung cancer

ESMO 2023 Highlights on lung cancer

2024-02-0810:31

Expert: Mohamed Emam Sobeih, National Cancer Institute Cairo, Nasr City, Egypt
Cyclophosphamide induced severe hyponatremia with encephalopathy and seizure in a patient with locally advanced breast cancer

Cyclophosphamide induced severe hyponatremia with encephalopathy and seizure in a patient with locally advanced breast cancer

2024-01-2504:44

Expert: Sofiko Sharashenidze, Mardaleishvili Medical Centre, Tbilisi, Georgia
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

2024-01-2403:57

Expert: Salah Mabrouk Khallaf, South Egypt Cancer Institute, Assiut, Egypt
Radiotherapy as a local hemostatic agent in cancer patients

Radiotherapy as a local hemostatic agent in cancer patients

2023-11-3008:20

Expert: Mohammad Nasser Ahmed, National Oncology Center, Sanaa, Yemen Republic
News on Breast Cancer from ESMO 2023

News on Breast Cancer from ESMO 2023

2023-11-2307:38

Expert: Elvina Almuradova, Medicana International Hospital, Izmir, Turkey
Challenge of diagnosis of metachronous ovarian metastases in a young patients with primary colorectal cancer

Challenge of diagnosis of metachronous ovarian metastases in a young patients with primary colorectal cancer

2023-11-1607:04

Expert: Zaiana Sangadzhieva, Institute for Personalized Oncology of Sechenov University, Moscow, RU
How to make the treatment choice in localized adenocarcinoma of the lower oesophagus and GEJ after the NeoAegis trial results

How to make the treatment choice in localized adenocarcinoma of the lower oesophagus and GEJ after the NeoAegis trial results

2023-11-0907:41

Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil
ESO Experiences

ESO Experiences

2023-11-0212:00

Expert: Rita Canario, University of Porto, Porto, Portugal
THE ERA OF CDK4/6 inhibitors in early breast cancer concerning staging the axilla. A surgeon’s perspective

THE ERA OF CDK4/6 inhibitors in early breast cancer concerning staging the axilla. A surgeon’s perspective

2023-10-2613:43

Expert: Lazaros Papadopoulos, IASO Gynecological Clinic, Athens, Greece
SELNET clinical practice guidelines for bone sarcoma

SELNET clinical practice guidelines for bone sarcoma

2023-10-1906:08

Expert: Bruna David, National Cancer Institute, Rio de Janeiro, Brazil
Switching treatment paradigms and the difficulties with this

Switching treatment paradigms and the difficulties with this

2023-10-1216:19

Experts: Sara Ramella, Campus Bio-Medico University, Rome, Italy Pierfilippo Crucitti, Campus Bio-Medico University, Rome, Italy
loading
Comments 
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States